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Objective To determine the incidence of toxin-A-negative/toxin-B-positive Clostridium difficile strains and
their genetic relatedness in the feces of patients suffering from antibiotic-associated diarrhea (AAD) in Polish
hospitals.
Methods C. difficile strains were cultured from patients’ stool samples. The present study characterises these
strains with respect to their cytopathogenicity on McCoy cells and the absence of toxin A despite a functional
toxin B as determined with commercial test kits (Culturette Brand Toxin CD-TCD toxin A test and
C. difficile Tox A/B test). In addition, PCR using different primer pairs aiming at non-repeating or repeating
regions of the toxin A and B genes were used to confirm the findings. All toxin A– Bþ strains were genetically
characterised by random amplification of polymorphic DNA (RAPD) analysis, PCR ribotyping and, in
part, pulsed-field gel electrophoresis (PFGE) of DNA macrorestriction fragments.
Results We here present the presence of 17 toxin A– Bþ strains among 159 C. difficile strains (11%) isolated
from fecal samples from 413 patients with antibiotic-associated diarrhea. All 17 strains possessed the toxin B
gene, demonstrated a cytopathogenic effect on the McCoy cells, and were positive in the Tox A/B test.
Molecular typing of these 17 C. difficile strains revealed that 7 of 17 (41%) toxin A–/BþC. difficile strains could
not be discriminated. It appeared that these strains had a genotype that could not be distinguished from that of
a Japanese control strain.
Conclusion Our observations imply that a particular genotype of toxin A–BþC. difficile has spread extensively,
not only in Poland but possibly even worldwide.
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INTRODUCTION
Clostridium difficile, an anaerobic pathogen encountered in
animal and human enteric diseases, generally produces two
major virulence factors: exotoxins A and B. These toxins are the
largest bacterial toxins known (molecular weights 308 000 and
279 000, respectively). Toxin A is a potent enterotoxin, lethal
and cytotoxic, and probably causes most of the clinical symp-
toms as an immediate consequence of induced fluid secretion
and significant mucosal damage. Toxin B is approximately 1000
times more cytotoxic than toxin A [1]. Toxins A and B activate
the release of cytokines from human monocytes, and this effect
is responsible for colon inflammation in pseudomembranous
colitis (PMC) [2–4]. Different PCR assays for the detection of
repeating [5] and non-repeating [6,7] domains in the C. difficile
toxin genes were described for diagnostic purposes. Non-
toxigenic strains of C. difficile lacking either or both of the
genes for toxin A and B are generally considered to be non-
pathogenic. However, a number of intriguing questions remain
with regard to the pathogenicity of these toxin A–/BþC. difficile
strains, one of which appeared to be lethal when introduced
into an animal model [8]. Moreover, in 1999, an outbreak of
toxin A– Bþ C. difficile-associated diarrhea in a Canadian ter-
tiary-care hospital was described [9]. A certain prevalence of
toxin A– Bþ C. difficile strains was described in the UK as well
[10]. Similar C. difficile strains were isolated from fecal samples of
patients with antibiotic-associated diarrhea (AAD) in Poland
[11]. Toxin A–/BþC. difficile strains have deletions in the region
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of the repetitive domain in the toxin A gene, which encodes the
epitope that is responsible for the reaction with the antiserum
against native toxin A [12]. The aim of the present study was to
define the incidence of toxin A– Bþ C. difficile strains among
patients suffering from AAD and to analyze the toxicity and
genetic heterogeneity of these strains.
MATERIALS AND METHODS
Stool samples
Stool specimens (n¼ 413) were obtained for routine surveil-
lance cultures from as many patients as possible suffering from
AAD and hospitalised in different wards of various hospitals in
Warsaw between 1995 and 1999. All patients were pretreated
with antibiotics and suffered from watery diarrhea and abdom-
inal pain. Among the patients, 60 were nursed on a single
transplantation ward, 34 from orthopedics, 62 from internal
medicine, 36 from surgery, 12 from intensive care, and 79 from
pediatrics, whereas the remaining 130 patients were nursed in
various other departments, including gynecology, dermatology,
the outpatient clinic and others. Stool samples were tested for
the presence of C. difficile toxins A and B and were cultured for
isolation of C. difficile.
Isolation of bacterial strains
Fecal samples were cultured on selective Columbia agar with
cycloserine–cefoxitine–amphotericin B (CCCA medium, bio-
Merieux, Marcy-l’Etoile, France), as described previously [13].
Plates were incubated anaerobically at 37 8C for at least 96 h.
Isolates were identified as C. difficile by the characteristic
morphology of colonies, specific horse odor, green–yellow
fluorescence under UV light, Gram staining and biochemical
tests (API-20 A, bioMerieux).
Strains
Seventeen suspected toxin A– Bþ strains of C. difficile were
isolated from patients with AAD. Three reference strains
were included for comparative reasons. The reference set
consisted of a single toxigenic strain (VPI 10463), a non-
toxigenic isolate (NIH BRRIGS 8050), and one toxin A–Bþ
strain of C. difficile, isolated by Dr H. Kato (strain GAI 95601,
Institute of Anaerobic Bacteriology, Gifu University School of
Medicine, Japan).
EIA detection of C. difficile toxins A and B
For detection of toxins A and B, one colony was cultured
anaerobically in BHI medium for 4 days. Supernatants were
collected by centrifugation (3000 g for 15 min) and filtered
through 0.45 mm membranes. Toxin A was detected by enzy-
matic immunoassays. The Culturette Brand Toxin CD-TCD
toxin A test (Becton-Dickinson, Meyland, France) was per-
formed according to the manufacturer’s instructions. Briefly,
horseradish peroxidase-conjugated anti-C. difficile toxin A poly-
clonal antibody and 100 mL of supernatant were added to the
microwells and incubated at 37 8C for 1 h. The microwells were
washed, and chromogenic substrate was added and incubated at
room temperature for 10 min. Reactions were stopped by
adding one drop of stop solution and read visually. For detection
of either or both of the toxins, Tox A/B C. difficile tests
(TechLab, Inc., Blacksburg, VA, USA) were performed accord-
ing to the manufacturer’s instructions. One drop of conjugate
per microwell was added, followed by the addition of two drops
of tested sample prepared as described above. Microwells were
incubated at 37 8C for 50 min and washed five times with wash
solution. One drop of tetramethylbenzidine substrate was
added, followed by one drop of hydrogen peroxide in citric
acid buffer. After a 10 min incubation at room temperature,
reactions were stopped by adding one drop of stop solution. Test
results were interpreted by visual reading: a colorless result was
considered negative; any yellow color was considered positive.
Toxin B detection onMcCoy cells
In vitro cytotoxin B determination was performed with McCoy
cells cultured as described previously [11]. One colony of a C.
difficile strain was used to inoculate BHI medium and incubated
anaerobically. Supernatant fluids were collected as described
above. Tenfold serial dilutions of culture filtrate were added in
duplicate to McCoy cells and incubated for 24 h at 37 8C in a 5%
CO2 atmosphere. The cytopathogenic effect (CPE) was
observed by inverse microscopy [14]. If this CPE could be
neutralised by polyclonal goat anti-C. difficile toxin B antiserum,
the test was considered positive.
Genotyping of C. difficile strains by arbitrary primed PCR and
PCR ribotyping
AP-PCR was performed using two independent arbitrary
primers AP-1 and AP-7 in separate assays. PCR-mediated
ribotyping employed the consensus primers SP1 and SP2. Both
PCR tests were performed as described previously [15].
PCR assay for the detection of the toxin A and B genes
For straightforward detection of the toxin A and toxin B genes,
PCR was performed by use of the YT28/YT29 and YT17/
YT18 primer sets, respectively, as described previously [7,14].
The cycling conditions for both PCRs were: one predenatura-
tion cycle at 94 8C for 2 min, followed by 94 8C for 45 s, 55 8C
for 30 s, and 70 8C for 45 s, for 35 cycles.
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PCR assays for the detection of variants of the toxin A gene
PCR amplification aiming at the repeats in the toxin A gene was
performed as described by Kato et al. [12]. Briefly, 2mL of DNA
solution obtained as described previously [13] was added to
22.5 mL of Supermix (Gibco, BRL, Karlsruhe, Germany), and
1 mL of each primer solution (NK9/NKV011). The cycling
conditions applied during PCR were 95 8C for 20 s and 60 8C
for 2 min for 40 cycles.
Pulsed-field gel electrophoresis
PFGE was performed by a method described previously [16]. C.
difficile strains were grown anaerobically on Brucella blood agar
at 37 8C for 48 h. Between two and five colonies were
embedded in 1% agarose (InCert agarose; FMC BioProducts,
Rockland, ME, USA). Each agarose plug was transferred to a
sterile cup with 1 mL of proteolytic buffer and incubated
overnight at 37 8C. Restriction was performed by placing a
5 mm slice of each plug into 120 mL of restriction buffer for
2 30 min and finally in 120 mL of restriction mixture with the
appropriate restriction enzyme. Macrorestriction of the DNA
was accomplished with SmaI or NruI (Boehringer Mannheim,
Mannheim, Germany). Restriction fragments were separated
by electrophoresis in a 1% Seakem-GTG agarose gel (FMC Bio
Products) in 0045 M Tris-HCl, pH 7.5, 0045 M boric acid,
0001 M EDTA. The run time was 20 h at 6 V/cm, with a
linearly ramped pulse time (0.5–40 s).
RESULTS
From the 413 stool samples C. difficile could be cultured in 159
cases (39%). Of these strains, 120 were toxin Aþ as demon-
strated by use of the TCD test. Of the remaining 39 strains, 17
showed a clear CPE on the McCoy cells. For these 17 strains,
which were isolated throughout the entire study period from
patients nursed in various departments (no-outbreak situation),
the results of C. difficile toxin testing are presented in Table 1. All
strains were cytotoxic for McCoy cells, an effect that could be
neutralised by polyclonal antiserum. Interestingly, there was no
apparent difference in the severity of the CPE caused by culture
supernatants of toxin A– Bþ or toxin AþBþ C. difficile strains.
This contrasts with earlier reports [8,17]. Toxin A could not be
detected by the TCD toxin A test. Toxin A/B tests gave positive
results for all 17 clinical cases. The conserved regions of both
toxin genes were detectable in all of the Polish isolates studied by
the diagnostic PCR tests. The PCR product obtained upon
amplification of the non-repeating unit was the same for all
toxin A– Bþ strains and the reference strains.
By PCR ribotyping, we distinguished nine different types
among the 17 A– BþC. difficile strains. Results of AP-PCR were
concordant with those obtained by PCR ribotyping, although a
smaller number of types was identified. Altogether, 11 types
were distinguishable on the basis of combined PCR ribotyping
and AP-PCR (three-letter code in Table 1; for examples of
experimental data, see Figure 1). Seven strains, however, were
clustered on the basis of the ribotyping and AP-PCR data.
These strains were not linked in time or place and were derived
from children as well as from adults. These individuals were
nursed in a variety of departments, including hematology,
gastroenterology, neurology, internal medicine, surgery and
orthopedics. Interestingly, the Japanese reference strain showed
the same ‘A-type’. PFGE was frustrated by the fact that eight
strains were untypable, which confirmed similar difficulties for
toxin AþBþ strains as described by other investigators.
Although DNA degradation could not be prevented by for-
maldehyde treatment of bacteria, it might still be worthwhile
for future attempts to prepare the agarose plugs using younger
cultures [18]. It is interesting to note, however, that toxin A– Bþ
strains behave similarly to toxin AþBþ strains as far as PFGE is
concerned. PFGE of the other nine strains identified three and
five different types using NruI and SmaI enzymes, respectively.
Both reference strains, toxigenic and non-toxigenic, were
Figure1Genotypic characterisationofC. difficile strains. (A) Results of PCR
ribotyping for four different strains. Strain numbers are indicated above the
lanes and the corresponding types are A, H, I and A from left to right. (B)
Results of an RAPD test employing primerAP7. Note that the banding pat-
terns for strains1, 3, 4, 5, 6 and 9, representing the prevalent A-type, are in-
discriminate. On the left of bothpanels, the 600-bpDNA sizemarker band is
indicated (M:100-bp size ladder (Bio-Rad,Veenendaal,The Netherlands)).
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confirmed to be completely different types. Four strains (num-
bers 1, 6, 9 and 13) were clonally related, belonging to the
already mentioned A-type. One strain (number 5) demon-
strated single-fragment differences with the A-type when SmaI
was used. The Japanese C. difficile strain belonged to the A-type.
For nine toxin A–Bþ C. difficile strains, PCR amplification with
the NK9/NKV011 primer set generated a PCR product
(700 bp) similar to that obtained for the Japanese GAI 95601
strain. Interestingly, all clinical strains that displayed ribotype A
had a deletion in the A gene. PCR analysis of the remaining
eight toxin A– Bþ C. difficile strains revealed an amplicon with
the expected size of approximately 2500 bp.
DISCUSSION
We analysed fecal samples of a large group of patients suspected
of having AAD over a 5-year surveillance period. In 39% of all
samples, C. difficile was encountered and, to our surprise, 11% of
these isolates failed to express toxin A. These 17 toxin A–Bþ C.
difficile strains were negative in the TCD immunoassay and
positive in the Tox A/B test, designed for detection of both
toxins. All 17 strains demonstrated a cytopathogenic effect on
McCoy cells, and this effect was neutralised by C. difficile
antitoxin. Both toxin genes were detected in our 17 strains,
the toxigenic reference strain and the Japanese toxin A– Bþ
strain. Only the non-toxigenic reference strain lacked both
toxin genes. It is well known that both toxins of C. difficile
possess repeating units at the C-terminus. The repeating units of
the toxin A represent the part recognised by the monoclonal
antibody. Deletions in the repeating sequences of the toxin gene
in toxin A– Bþ strains were demonstrated by Kato and cow-
orkers [12]. Similar deletions as identified by PCR were the
reason why our strains demonstrated negative reactions in
the toxin A TCD enzymatic test. Toxin A– Bþ strains without
the overt deletion in the repeat region were shown to produce
minute amounts of toxin A: more than twofold concentration
of culture supernatants produced a small signal (results not
shown). It could be that this represents read-through products
of a mutated toxin A gene, as described by Von Eichel-Streiber
et al. [19]. We have not yet confirmed this by sequence analysis
(work in progress). Recently, Japanese authors described a PCR
with specific primers for detection of toxin A–Bþ C. difficile
strains directly in stool samples, a valuable tool for future
epidemiologic studies [17].
In this study, we investigated unrelated, clinical C. difficile
isolates from different hospital units found at different moments
in time. Nevertheless, we found seven toxin A–Bþ C. difficile
strains belonging to a single genogroup A, being similar to the
Japanese strain (number 18, Table 1). The clonal isolates,
furthermore, share high-level resistance against clindamycin
Table1 Characterisation of Polish toxin A^BþC. difficile strains
Toxin PCRd
TCDa A/Bb
McCoyc
Cytotoxicity A B
RAPD
AP1
RAPD
AP7
PCR
ribotyping
PFGE
NruI
PFGE
SmaI
1. 2428/95 ^ þ 10^5 þ þ A A A A A
2. 428/97 ^ þ 10^6 þ þ A B B B B
3. 1236/97 ^ þ 10^6 þ þ A A C NT NT
4. 1461/97 ^ þ 10^2 þ þ A A D NT NT
5. 2785/97 ^ þ 10^3 þ þ A A A A C
6. 2887/97 ^ þ 10^3 þ þ A A A A A
7. 399/98 ^ þ 10^5 þ þ A C A A A
8. 570/98 ^ þ 10^3 þ þ B D E NT NT
9. 592/98 ^ þ 10^3 þ þ A A A A A
10. 1110/98 ^ þ 10^3 þ þ A A A NT NT
11. 2233/98 ^ þ 10^4 þ þ A A A NT NT
12. 2560/98 ^ þ 10^3 þ þ A E F NT NT
13. 2601/98 ^ þ 10^3 þ þ A A A A A
14. 3120/98 ^ þ 10^4 þ þ A A G NT NT
15. 205/99 ^ þ 10^1 þ þ C G A A D
16. 558/99 ^ þ 10^3 þ þ B F H C E
17. P183/99 ^ þ 10^1 þ þ A A I NT NT
18. GAI 95601e ^ þ 10^3 þ þ A A A A A
19. VPI10463f þ þ 10^3 þ þ A A C D F
20. IHBRIGGS 8050g ^ ^ ^ ^ ^ A A J E G
aTCD, Culturette BrandToxin CD C. difficile toxin A (Becton Dickinson, Franklinokes, NJ, USA); bC. difficileTOX A/B TEST; clast dilution of supernatants, de-
monstrated cytopathic effect; dtoxin A and B genes were detected in PCR by usingYT-28/YT-29 andYT-17/YT-18 primers, respectively; eC. difficile toxin-A-
negative toxin-B-positive-strain isolated inJapan; ftoxigenic reference strain; gnon-toxigenic reference strains; NT, non-typable.
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and harbor the ermB gene (results not shown). This strongly
suggests widespread dissemination of certain clones of toxin
A–BþC. difficile, which emphasises that additional studies on the
role and mechanisms of intercontinental spread of these appar-
ently pathogenic bacterial pathogens should be undertaken.
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